Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)

Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)

US Patent 11384335 · Granted Jul 12, 2022

Estimated economic value: $3,305,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2023
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2023
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2022
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2022
Co-stimulatory domains for use in genetically-modified cells2022
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2021
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2021
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2021
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2021
Co-stimulatory domains for use in genetically-modified cells2020
Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory2020
Analysis method for interpreting Taylor dispersion data2020